- Home
- PMCB vs SHFS Comparison
PMCB vs SHFS Comparison
Compare PMCB & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- SHFS
- Stock Information
- Founded
- PMCB 1996
- SHFS 2015
- Country
- PMCB United States
- SHFS United States
- Employees
- PMCB N/A
- SHFS N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- SHFS Finance: Consumer Services
- Sector
- PMCB Health Care
- SHFS Finance
- Exchange
- PMCB Nasdaq
- SHFS Nasdaq
- Market Cap
- PMCB 7.3M
- SHFS 6.2M
- IPO Year
- PMCB N/A
- SHFS N/A
- Fundamental
- Price
- PMCB $1.11
- SHFS $2.17
- Analyst Decision
- PMCB
- SHFS
- Analyst Count
- PMCB 0
- SHFS 0
- Target Price
- PMCB N/A
- SHFS N/A
- AVG Volume (30 Days)
- PMCB 12.0K
- SHFS 10.3K
- Earning Date
- PMCB 08-12-2025
- SHFS 08-13-2025
- Dividend Yield
- PMCB N/A
- SHFS N/A
- EPS Growth
- PMCB N/A
- SHFS N/A
- EPS
- PMCB 1.29
- SHFS N/A
- Revenue
- PMCB N/A
- SHFS $13,956,453.00
- Revenue This Year
- PMCB N/A
- SHFS N/A
- Revenue Next Year
- PMCB N/A
- SHFS N/A
- P/E Ratio
- PMCB $0.86
- SHFS N/A
- Revenue Growth
- PMCB N/A
- SHFS N/A
- 52 Week Low
- PMCB $1.00
- SHFS $1.84
- 52 Week High
- PMCB $2.42
- SHFS $14.86
- Technical
- Relative Strength Index (RSI)
- PMCB 54.71
- SHFS 43.20
- Support Level
- PMCB $1.00
- SHFS $2.03
- Resistance Level
- PMCB $1.07
- SHFS $2.40
- Average True Range (ATR)
- PMCB 0.05
- SHFS 0.14
- MACD
- PMCB 0.01
- SHFS 0.01
- Stochastic Oscillator
- PMCB 73.33
- SHFS 42.47
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.